211 related articles for article (PubMed ID: 10212525)
41. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
42. GATT and the gap: how to save lives.
James JS
AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123
[TBL] [Abstract][Full Text] [Related]
43. Protecting Pharmaceutical Patents and Test Data: How the Trans-Pacific Partnership Agreement Could Affect Access to Medicines in the US and Abroad.
Luo J; Kesselheim AS
AMA J Ethics; 2016 Jul; 18(7):727-35. PubMed ID: 27437823
[TBL] [Abstract][Full Text] [Related]
44. Access to AIDS medicines stumbles on trade rules.
Wise J
Bull World Health Organ; 2006 May; 84(5):342-4. PubMed ID: 16710536
[No Abstract] [Full Text] [Related]
45. Improving access to essential drugs for people living with HIV/AIDS.
Balasubramaniam K
Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
[No Abstract] [Full Text] [Related]
46. Not just a tragedy: access to medications as a right under international law.
Yamin AE
Boston Univ Int Law J; 2003; 21(2):325-71. PubMed ID: 16514750
[No Abstract] [Full Text] [Related]
47. No deal in sight on cheap drugs for poor countries.
Fleck F
Bull World Health Organ; 2003; 81(4):307-8. PubMed ID: 12764500
[No Abstract] [Full Text] [Related]
48. Progress in global access to medicines threatened by funding shortfalls, warns charity.
Moszynski P
BMJ; 2011 Dec; 343():d8322. PubMed ID: 22205708
[No Abstract] [Full Text] [Related]
49. Reprivatizing pharmaceutical supplies in Africa.
Turshen M
J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
[TBL] [Abstract][Full Text] [Related]
50. Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals.
Correa CM
Chic J Int Law; 2002; 3(1):69-85. PubMed ID: 15709300
[No Abstract] [Full Text] [Related]
51. Introductory note: The access to Essential Medicines Campaign.
Kindermans JM; Matthys F
Trop Med Int Health; 2001 Nov; 6(11):955-6. PubMed ID: 11703852
[TBL] [Abstract][Full Text] [Related]
52. Providing affordable essential medicines to African households: the missing policies and institutions for price containment.
Tetteh Ek
Soc Sci Med; 2008 Feb; 66(3):569-81. PubMed ID: 18023953
[TBL] [Abstract][Full Text] [Related]
53. Health GAP coalition--new group for international treatment access.
AIDS Treat News; 1999 Mar; (No 315):5-6. PubMed ID: 11366560
[TBL] [Abstract][Full Text] [Related]
54. Patent law--balancing profit maximization and public access to technology.
Beckerman-Rodau A
Columbia Sci Technol Law Rev; 2003; 4():E1. PubMed ID: 15977333
[TBL] [Abstract][Full Text] [Related]
55. Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
Dionisio D; Cao Y; Hongzhou L; Kraisintu K; Messeri D
Curr HIV Res; 2006 Jan; 4(1):3-20. PubMed ID: 16454707
[TBL] [Abstract][Full Text] [Related]
56. Health and intellectual property rights.
Correa CM
Bull World Health Organ; 2001; 79(5):381. PubMed ID: 11417031
[No Abstract] [Full Text] [Related]
57. [Access for all to quality drugs].
Videau JY
Med Trop (Mars); 2002; 62(4):396-400. PubMed ID: 12534178
[TBL] [Abstract][Full Text] [Related]
58. International assistance and cooperation for access to essential medicines.
Mok EA
Health Hum Rights; 2010 Jun; 12(1):73-81. PubMed ID: 20930255
[TBL] [Abstract][Full Text] [Related]
59. US trade rules seek to balance health and patent protection.
Wadman M; Cherry M
Nature; 1999 Dec; 402(6762):567-8. PubMed ID: 10604448
[No Abstract] [Full Text] [Related]
60. Intellectual property under GATT.
Nature; 1993 Dec; 366(6456):587-8. PubMed ID: 8259195
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
